marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2024-Q3
hinzugefügt 13.11.2024
Leap Therapeutics Bilanz 2011-2024 | LPTX
Bilanz Jährlich Leap Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-64.8 M | -114 M | -51.5 M | -2.86 M | -16.3 M | -25.7 M | 29.5 M | -21 M | -10.9 M | -19 M | -15.3 M | - | |
Langfristige Schulden |
- | 262 K | 37 K | - | - | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
262 K | 416 K | 432 K | 408 K | 474 K | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | 348 K | 711 K | 3.45 M | 11.9 M | 70.5 M | - | - | - | 3.11 M | - |
Kurzfristige Verbindlichkeiten |
12.7 M | 11.2 M | 9.99 M | 7.37 M | 8.49 M | 6.45 M | 6.08 M | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
12.7 M | 11.5 M | 10 M | 7.72 M | 9.2 M | 9.9 M | 17.9 M | 6.46 M | 1.28 M | 2.49 M | 1.97 M | 4.61 M | - |
Aufgeschobenes Einkommen |
- | - | - | 1.5 M | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-400 M | -318 M | -264 M | -223 M | -195 M | -154 M | -130 M | -101 M | -89.3 M | -68.2 M | -42.7 M | -24.4 M | - |
Vermögenswerte |
72.8 M | 70.4 M | 118 M | 54.4 M | 7.45 M | 19.1 M | 29.1 M | 6.46 M | 28.1 M | 48.7 M | 20.7 M | 17.7 M | - |
Zahlungsmittel |
70.6 M | 65.5 M | 115 M | 52.1 M | 3.89 M | 16.3 M | 25.7 M | - | - | - | - | - | - |
Buchwert |
60.1 M | 58.9 M | 108 M | 46.7 M | -1.75 M | 9.18 M | 11.1 M | - | 26.9 M | 46.2 M | 18.8 M | 13.1 M | - |
Gesamtes Eigenkapital |
60.1 M | 58.9 M | 108 M | 46.7 M | -1.75 M | 9.18 M | 11.1 M | -100 M | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Leap Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
- | 39 K | 154 K | - | - | 38 K | 152 K | 262 K | 369 K | 474 K | - | 37 K | - | - | 36 K | 144 K | 144 K | 144 K | 144 K | 552 K | 552 K | 552 K | 552 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
16.1 M | 15.6 M | 10.6 M | 12.7 M | 11 M | 11.8 M | 10.5 M | 11.5 M | 12.1 M | 10.9 M | 7.34 M | 10 M | 11.3 M | 8.06 M | 7.43 M | 7.72 M | 7.72 M | 7.72 M | 7.72 M | 9.2 M | 9.2 M | 9.2 M | 9.2 M | 9.9 M | 9.9 M | 9.9 M | 9.9 M | 17.9 M | 17.9 M | 17.9 M | 17.9 M | 36.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | 375 K | 750 K | 1.12 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-452 M | -434 M | -413 M | -400 M | -387 M | -373 M | -360 M | -318 M | -306 M | -291 M | -274 M | -264 M | -253 M | -242 M | -232 M | -223 M | -223 M | -223 M | -223 M | -195 M | -195 M | -195 M | -195 M | -154 M | -154 M | -154 M | -154 M | -130 M | -130 M | -130 M | -130 M | -101 M | -101 M | -101 M | -101 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
65 M | 81.4 M | 58 M | 72.8 M | 83 M | 95.9 M | 107 M | 70.4 M | 82.2 M | 94.2 M | 106 M | 118 M | 128 M | 37.9 M | 45.8 M | 54.4 M | 54.4 M | 54.4 M | 54.4 M | 7.45 M | 7.45 M | 7.45 M | 7.45 M | 19.1 M | 19.1 M | 19.1 M | 19.1 M | 29.1 M | 29.1 M | 29.1 M | 29.1 M | 6.46 M | 6.46 M | 6.46 M | 6.46 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
62.8 M | 78.5 M | 54.9 M | 70.6 M | 80.7 M | 91.4 M | 102 M | 65.5 M | 78.3 M | 90.9 M | 103 M | 115 M | 125 M | 35.7 M | 43.5 M | 52.1 M | 52.1 M | 52.1 M | 52.1 M | 3.89 M | 3.89 M | 3.89 M | 3.89 M | 16.3 M | 16.3 M | 16.3 M | 16.3 M | 25.7 M | 25.7 M | 25.7 M | 25.7 M | 793 K | 793 K | 793 K | 793 K | 405 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
49 M | 65.8 M | 47.4 M | 60.1 M | 72 M | 84.1 M | 96 M | 58.9 M | 70.1 M | 83.3 M | 98.6 M | 108 M | 117 M | 29.9 M | 38.4 M | 46.7 M | 46.7 M | 46.7 M | 46.7 M | -1.75 M | -1.75 M | -1.75 M | -1.75 M | 9.18 M | 9.18 M | 9.18 M | 9.18 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | -29.7 M | 6.46 M | 6.46 M | 6.46 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
49 M | 65.8 M | 47.4 M | 60.1 M | 72 M | 84.1 M | 28.3 M | 58.9 M | 70.1 M | 83.3 M | 98.6 M | 108 M | 117 M | 29.9 M | 38.4 M | 46.7 M | 46.7 M | 46.7 M | 46.7 M | -1.75 M | -1.75 M | -1.75 M | -1.75 M | 9.18 M | 9.18 M | 9.18 M | 9.18 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | -100 M | -100 M | -100 M | -100 M | -70.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung